2020
DOI: 10.1016/j.biopsych.2019.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Neurostructural Heterogeneity in Youths With Internalizing Symptoms

Abstract: Internalizing disorders such as anxiety and depression are the most common psychiatric disorders, frequently begin in youth, and exhibit marked heterogeneity in treatment response and clinical course. It is increasingly recognized that symptom-based classification approaches to internalizing disorders do not align with underlying neurobiology. An alternative to classifying psychopathology based on clinical symptoms is to identify neurobiologically-informed subtypes based on brain imaging data. We used a recent… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
28
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 40 publications
(29 citation statements)
references
References 83 publications
1
28
0
Order By: Relevance
“…The wealth of available data and advances in machine learning intensified efforts to redefine disorder categories using datadriven methods. Previous studies stratified psychiatric disorders mostly by clustering single domains (e.g., psychometry [6][7][8][9][10], neuroimaging [11][12][13][14][15][16], biochemical markers [17], or genetics [18,19]) or by analyzing patients from a single diagnosis (e.g., major depressive disorder (MDD) [5,7,11,[18][19][20][21][22] or schizophrenia (SCZ) [23][24][25][26][27][28]). Previous transdiagnostic clustering studies support the existence of diagnostically mixed subtypes across two [29][30][31] or more disorders [32][33][34][35].…”
Section: Introductionmentioning
confidence: 99%
“…The wealth of available data and advances in machine learning intensified efforts to redefine disorder categories using datadriven methods. Previous studies stratified psychiatric disorders mostly by clustering single domains (e.g., psychometry [6][7][8][9][10], neuroimaging [11][12][13][14][15][16], biochemical markers [17], or genetics [18,19]) or by analyzing patients from a single diagnosis (e.g., major depressive disorder (MDD) [5,7,11,[18][19][20][21][22] or schizophrenia (SCZ) [23][24][25][26][27][28]). Previous transdiagnostic clustering studies support the existence of diagnostically mixed subtypes across two [29][30][31] or more disorders [32][33][34][35].…”
Section: Introductionmentioning
confidence: 99%
“…There were few associations between our validity metrics and clinical diagnoses of depression, PTSD, anxiety, psychosis spectrum disorders, or externalizing disorders, supporting the potential validity of our approach. This feature is especially relevant considering neurocognitive performance differences in these conditions from prior work (e.g., Barzilay et al, 2019;Gur et al, 2014;Kaczkurkin et al, 2020;Service et al, 2020). However, there were diagnoses with reduced validity metrics that should be addressed.…”
Section: Discussionmentioning
confidence: 99%
“…A second potential reason for limited effect sizes (even with the use of multivariate methods like CCA) is between-subject heterogeneity. A first potential type of heterogeneity is diversity in symptoms, such that two patients with depression may present with largely non-overlapping symptom profiles [Drysdale et al, 2017; Feczko et al, 2019; Feczko and Fair, 2020; Kaczkurkin et al, 2020]. A second potential type of heterogeneity is diversity in psychophysiological disease mechanisms.…”
Section: Discussionmentioning
confidence: 99%